Dual Agonist GLP-1 + GIP
A dual-pathway peptide formulation combining GLP-1 and GIP receptor agonists designed to support appetite regulation, energy metabolism, and glucose balance through complementary mechanisms. By activating both GLP-1 and GIP pathways, this nasal formulation provides broader metabolic signaling than GLP-1 alone, while remaining gentle and suitable for daily use.
20 mg / 40 mg
>99%
160
Disclaimer: Dosing guides are provided as suggestions for prescribed use only in countries where the use of the respective peptides is legally permitted. These guides have not been approved by any regulatory authority and are not intended to constitute medical advice.
Protocol & Dosing
Use once or twice daily, typically in the morning or before meals where cravings occur. Nasal Triple Agonist has a short half-life, so consistent daily use provides the best results. Does NOT follow the weekly dose-escalation schedule used in injectable.
Key Benefits
Supports body recomposition, balances blood glucose levels, reduces cravings, promotes steady energy, enhances metabolic efficiency, and supports consistent appetite control when used daily.
Guidance
- Start with 1 spray, then wait 24–48 hours to assess appetite response
- Increase slowly only if needed
- Once your "sweet spot" is found, remain consistent at that dose until you feel an adjustment is necessary
- Do not exceed 4 sprays per day unless directed
- Best used daily or every other day, not sporadically
- Can be used alone or alongside lifestyle changes
Zenith Nano™ Spray System
Nasal delivery is facilitated with the Zenith Nano™ Spray System — a proprietary liquid ion delivery platform engineered for enhanced bioavailability, deep tissue penetration, and improved compound stability without compromising safety. Unlike carriers that rely on encapsulation, it enables direct solubilization and optimized partitioning of actives including peptides and coenzymes — no liposomes, no lipid nanoparticles, no emulsifier-dependent payloads. Built from amino acids and endogenous molecules for biocompatibility; scalable across routes that include intranasal sprays.
Compliance · Zenith Nano™ Peptides
cGMP manufacturing & cryopreservation
Manufactured through Pacific Manufacturing & Design LLC — GMP-certified under NSF/ANSI 455-2 and FDA-registered (Reg. No. 15492349536). Compliant with 21 CFR Parts 11, 111, and 117. Strict quality control, validated processes, and full traceability from raw material to final product.
Third-Party COA — Every Batch
Third-party COA for every batch, ensuring consistent quality and purity. Verified through LCMS and endotoxin testing, with full traceability from raw material to final product.